Nasal Polyps Treatment Market Share

Market Share of Nasal Polyps Treatment Industry

The Nasal Polyps Treatment Market is moderately competitive and consists of several major players. Few of the major players are developing novel delivery systems to treat nasal polyps. which is expected to impel the global nasal polypstreatment market growth. For instance, in 2018, Intersect ENT Inc. launched SINUVA, a sinus implant containing mometasone furoate that is used to treat nasal polyps. Futhermore, few key players are entering into partnerships to develop and increase their market position globally. Some of the companies which are currently dominating the market are Sanofi S.A, OptiNose US, Merck & Co Inc, Intersect ENT Inc, and GlaxoSmithKline PLC

Nasal Polyps Treatment Market Leaders

1. Sanofi S.A

2. OptiNose US

3. Merck & Co Inc

4. Intersect ENT Inc

5. GlaxoSmithKline PLC

*Disclaimer: Major Players sorted in no particular order